The activation of peripheral 5-HT1A receptors can inhibit seminal vesicle contraction: An in vivo animal study

Ju Ton Hsieh, Shih Ping Liu, Hong Chiang Chang, Vincent F.S. Tsai, Chiang Ting Chien, Hong Jeng Yu, Chen Hsun Ho

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives: To elucidate the differential effects of stimulating various peripheral 5-HT receptor subtypes on the contractile response of seminal vesicles (SVs) induced by electrical stimulation (ES). Methods: Male Wistar rats (aged 12-14 weeks) were prepared as our previously established model, which allows an intraarterial injection of test agents to directly act on SV. Four selective 5-HT agonists8-OH-DPAT (5-HT1A), 5-nonyloxytryptamine (5-HT1B), BW723C86 (5-HT2B), and MK-212 (5-HT2C)were injected at various concentrations (from 10-8 to 10-4 mmol/kg). After an injection, the SV contractile response was recorded after ES of lesser splanchnic nerve was applied. Relationships between the concentration of an agonist and its effect on SV contraction were plotted and analyzed. Results: The peripheral injection of 5-HT1A agonist had a dose-dependent inhibitory effect on SV contraction and could achieve an inhibition of >50%; the IC50 was 3.16x10-6 mmol/kg. No significant effects were observed with the peripheral injection of 5-HT1B, 5-HT2B, or 5-HT2C agonist. Conclusions: Our in vivo animal study shows that the activation of peripheral 5-HT1A receptors can inhibit ES-induced SV contraction, whereas the activation of peripheral 5-HT1B, 5-HT2B, or 5-HT2C receptors has no significant effect. The results suggest that the peripheral 5-HT pathway is a potential therapeutic target of the treatment for premature ejaculation.

Original languageEnglish
Pages (from-to)376-379
Number of pages4
JournalUrology
Volume78
Issue number2
DOIs
Publication statusPublished - Aug 1 2011
Externally publishedYes

Fingerprint

Receptor, Serotonin, 5-HT1A
Seminal Vesicles
Electric Stimulation
Injections
Serotonin
Serotonin 5-HT2 Receptor Agonists
Premature Ejaculation
Receptor, Serotonin, 5-HT2C
Splanchnic Nerves
Serotonin 5-HT1 Receptor Agonists
Intra-Arterial Injections
Serotonin Receptors
Inhibitory Concentration 50
Wistar Rats
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

The activation of peripheral 5-HT1A receptors can inhibit seminal vesicle contraction : An in vivo animal study. / Hsieh, Ju Ton; Liu, Shih Ping; Chang, Hong Chiang; Tsai, Vincent F.S.; Chien, Chiang Ting; Yu, Hong Jeng; Ho, Chen Hsun.

In: Urology, Vol. 78, No. 2, 01.08.2011, p. 376-379.

Research output: Contribution to journalArticle

Hsieh, Ju Ton ; Liu, Shih Ping ; Chang, Hong Chiang ; Tsai, Vincent F.S. ; Chien, Chiang Ting ; Yu, Hong Jeng ; Ho, Chen Hsun. / The activation of peripheral 5-HT1A receptors can inhibit seminal vesicle contraction : An in vivo animal study. In: Urology. 2011 ; Vol. 78, No. 2. pp. 376-379.
@article{5188979fe3e2497b807801b1590f0cc8,
title = "The activation of peripheral 5-HT1A receptors can inhibit seminal vesicle contraction: An in vivo animal study",
abstract = "Objectives: To elucidate the differential effects of stimulating various peripheral 5-HT receptor subtypes on the contractile response of seminal vesicles (SVs) induced by electrical stimulation (ES). Methods: Male Wistar rats (aged 12-14 weeks) were prepared as our previously established model, which allows an intraarterial injection of test agents to directly act on SV. Four selective 5-HT agonists8-OH-DPAT (5-HT1A), 5-nonyloxytryptamine (5-HT1B), BW723C86 (5-HT2B), and MK-212 (5-HT2C)were injected at various concentrations (from 10-8 to 10-4 mmol/kg). After an injection, the SV contractile response was recorded after ES of lesser splanchnic nerve was applied. Relationships between the concentration of an agonist and its effect on SV contraction were plotted and analyzed. Results: The peripheral injection of 5-HT1A agonist had a dose-dependent inhibitory effect on SV contraction and could achieve an inhibition of >50{\%}; the IC50 was 3.16x10-6 mmol/kg. No significant effects were observed with the peripheral injection of 5-HT1B, 5-HT2B, or 5-HT2C agonist. Conclusions: Our in vivo animal study shows that the activation of peripheral 5-HT1A receptors can inhibit ES-induced SV contraction, whereas the activation of peripheral 5-HT1B, 5-HT2B, or 5-HT2C receptors has no significant effect. The results suggest that the peripheral 5-HT pathway is a potential therapeutic target of the treatment for premature ejaculation.",
author = "Hsieh, {Ju Ton} and Liu, {Shih Ping} and Chang, {Hong Chiang} and Tsai, {Vincent F.S.} and Chien, {Chiang Ting} and Yu, {Hong Jeng} and Ho, {Chen Hsun}",
year = "2011",
month = "8",
day = "1",
doi = "10.1016/j.urology.2011.04.009",
language = "English",
volume = "78",
pages = "376--379",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - The activation of peripheral 5-HT1A receptors can inhibit seminal vesicle contraction

T2 - An in vivo animal study

AU - Hsieh, Ju Ton

AU - Liu, Shih Ping

AU - Chang, Hong Chiang

AU - Tsai, Vincent F.S.

AU - Chien, Chiang Ting

AU - Yu, Hong Jeng

AU - Ho, Chen Hsun

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Objectives: To elucidate the differential effects of stimulating various peripheral 5-HT receptor subtypes on the contractile response of seminal vesicles (SVs) induced by electrical stimulation (ES). Methods: Male Wistar rats (aged 12-14 weeks) were prepared as our previously established model, which allows an intraarterial injection of test agents to directly act on SV. Four selective 5-HT agonists8-OH-DPAT (5-HT1A), 5-nonyloxytryptamine (5-HT1B), BW723C86 (5-HT2B), and MK-212 (5-HT2C)were injected at various concentrations (from 10-8 to 10-4 mmol/kg). After an injection, the SV contractile response was recorded after ES of lesser splanchnic nerve was applied. Relationships between the concentration of an agonist and its effect on SV contraction were plotted and analyzed. Results: The peripheral injection of 5-HT1A agonist had a dose-dependent inhibitory effect on SV contraction and could achieve an inhibition of >50%; the IC50 was 3.16x10-6 mmol/kg. No significant effects were observed with the peripheral injection of 5-HT1B, 5-HT2B, or 5-HT2C agonist. Conclusions: Our in vivo animal study shows that the activation of peripheral 5-HT1A receptors can inhibit ES-induced SV contraction, whereas the activation of peripheral 5-HT1B, 5-HT2B, or 5-HT2C receptors has no significant effect. The results suggest that the peripheral 5-HT pathway is a potential therapeutic target of the treatment for premature ejaculation.

AB - Objectives: To elucidate the differential effects of stimulating various peripheral 5-HT receptor subtypes on the contractile response of seminal vesicles (SVs) induced by electrical stimulation (ES). Methods: Male Wistar rats (aged 12-14 weeks) were prepared as our previously established model, which allows an intraarterial injection of test agents to directly act on SV. Four selective 5-HT agonists8-OH-DPAT (5-HT1A), 5-nonyloxytryptamine (5-HT1B), BW723C86 (5-HT2B), and MK-212 (5-HT2C)were injected at various concentrations (from 10-8 to 10-4 mmol/kg). After an injection, the SV contractile response was recorded after ES of lesser splanchnic nerve was applied. Relationships between the concentration of an agonist and its effect on SV contraction were plotted and analyzed. Results: The peripheral injection of 5-HT1A agonist had a dose-dependent inhibitory effect on SV contraction and could achieve an inhibition of >50%; the IC50 was 3.16x10-6 mmol/kg. No significant effects were observed with the peripheral injection of 5-HT1B, 5-HT2B, or 5-HT2C agonist. Conclusions: Our in vivo animal study shows that the activation of peripheral 5-HT1A receptors can inhibit ES-induced SV contraction, whereas the activation of peripheral 5-HT1B, 5-HT2B, or 5-HT2C receptors has no significant effect. The results suggest that the peripheral 5-HT pathway is a potential therapeutic target of the treatment for premature ejaculation.

UR - http://www.scopus.com/inward/record.url?scp=80051472345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051472345&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2011.04.009

DO - 10.1016/j.urology.2011.04.009

M3 - Article

C2 - 21676447

AN - SCOPUS:80051472345

VL - 78

SP - 376

EP - 379

JO - Urology

JF - Urology

SN - 0090-4295

IS - 2

ER -